DSL(SH:603233)2024-04-28 07:47Financial Performance - The company's operating revenue for Q1 2024 was ¥6,751,925,018.36, representing a year-on-year increase of 13.54%[4] - The net profit attributable to shareholders was ¥398,450,103.92, showing a decrease of 19.79% compared to the same period last year[4] - Basic earnings per share decreased by 33.14% to ¥0.35[4] - Total operating revenue for Q1 2024 reached ¥6,751,925,018.36, an increase of 13.5% compared to ¥5,946,849,853.43 in Q1 2023[19] - The net profit for Q1 2024 is approximately ¥453.69 million, a decrease of 13.4% from ¥524.26 million in Q1 2023[21] - The operating profit for Q1 2024 is ¥570.86 million, down 16.5% from ¥684.09 million in Q1 2023[21] - The total comprehensive income for Q1 2024 is ¥453.69 million, down from ¥524.26 million in Q1 2023[22] - The net profit margin for Q1 2024 is approximately 8.3% for Q1 2024, compared to 8.0% in Q1 2023, indicating improved profitability[19] Cash Flow and Liquidity - The net cash flow from operating activities increased by 63.04% to ¥1,226,487,451.02[4] - The company reported cash and cash equivalents of CNY 5,360,914,687.12 as of March 31, 2024, up from CNY 4,416,348,231.47 on December 31, 2023[15] - The total cash inflow from operating activities in Q1 2024 is ¥8.99 billion, an increase of 27.1% from ¥7.08 billion in Q1 2023[24] - The total cash outflow from operating activities in Q1 2024 is ¥7.77 billion, compared to ¥6.33 billion in Q1 2023[24] - The net cash flow from financing activities was -216,455,182.02, compared to -326,902,371.26 in the previous period[25] - The net increase in cash and cash equivalents was 550,654,058.80, compared to a decrease of -206,911,956.06 in the previous period[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥25,365,701,681.98, up 5.15% from the end of the previous year[5] - Total liabilities increased to ¥16,907,547,803.94 in Q1 2024 from ¥16,190,216,085.34 in Q1 2023, marking a rise of 4.4%[18] - The company's equity attributable to shareholders rose to ¥7,294,816,720.73, up from ¥6,823,853,093.57, reflecting a growth of 6.9%[18] - Short-term borrowings increased to ¥884,720,617.09 in Q1 2024, compared to ¥733,214,982.14 in Q1 2023, indicating a rise of 20.6%[17] - Accounts payable reached ¥2,910,607,540.38, an increase from ¥2,746,148,492.79 in the previous year, showing a growth of 5.9%[17] Mergers and Acquisitions - The company completed 11 mergers and acquisitions in the industry during the reporting period, involving a total of 372 stores, with 168 stores signed but not yet delivered[11] - The company acquired 80% of Hefei Dekang Pharmacy Chain Co., Ltd. for CNY 25.35 million, involving 31 stores, with an additional capital increase of CNY 15 million[11] - The company purchased assets from Guangdong Evergrande Pharmacy Chain Co., Ltd. for CNY 67.63 million, covering 48 stores in Guangdong Province[11] - The company is in the process of acquiring 100% of Guangdong Runhe Pharmacy Chain Co., Ltd. for CNY 3.68 million, involving 9 stores[13] - The company is set to acquire 60% of Wuhan Dacanglin Jurong Pharmacy Chain Co., Ltd. for CNY 32.33 million, involving 49 stores, with an additional capital increase of CNY 10 million[13] - The company plans to acquire 60% of Daqing Baixing Kangcheng Pharmacy Chain Co., Ltd. for CNY 26.543 million, involving 112 stores[13] Operational Efficiency - Total operating costs for Q1 2024 were ¥6,195,248,019.99, up from ¥5,251,594,371.68 in Q1 2023, reflecting a year-over-year increase of 18.0%[19] - Gross profit margin for Q1 2024 was approximately 8.2%, down from the previous year's margin, indicating increased cost pressures[19] - Research and development expenses for Q1 2024 amounted to ¥12,796,450.05, a decrease of 12.5% from ¥14,620,833.25 in Q1 2023[19] Other Income and Expenses - Other income increased by 46.48% primarily due to an increase in VAT exemptions for small-scale taxpayers[8] - The company reported a decrease in interest income to ¥18.99 million in Q1 2024 from ¥19.52 million in Q1 2023[21] - The company did not recognize any significant non-recurring gains or losses that were not listed in the relevant guidelines[7] - The company did not apply new accounting standards or interpretations starting in 2024[25]